Company Overview of Alnylam Pharmaceuticals, Inc.
Phillip A. Sharp Ph.D.
Co-Founder, Director, Member of the Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 Board Members in 10 different organizations across 9 different industries.|
See Board Relationships
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships
Director and Member of Strategic Advisory Board
Co-Founder, Director, Member of the Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee
Director, Member of Scientific Advisory Board and Chairman of Compensation Committee
University of Illinois-Urbana-Champaign
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Ionis Pharmaceuticals, Inc.
|Edward M. Kaye M.D., Ph.D.||Chief Executive Officer, President, Chief Medical Officer and Director|
Sarepta Therapeutics, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Executive Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$490.0K||Compensation as of Fiscal Year 2015.|